Literature DB >> 1955762

Early steps of IgA B cell differentiation.

W Strober1, G R Harriman, D R Kunimoto.   

Abstract

The overall picture of IgA B cell differentiation to emerge from these studies is that sIgM-bearing 'virgin' B cells entering the Peyer's patches are subject to a microenvironment (most probably organ-specific stromal cells) which brings about initial or primary IgA switch differentiation. For reasons mentioned, this probably does not involve TGF-beta, which instead appears to operate on a cell, such as the CH12.LX B cell, which has already undergone the initial steps of IgA isotype switching. The next stage of IgA B cell differentiation involves a cell which expressed both sIgM and sIgA simultaneously and appears to produce C mu and C alpha mRNA transcripts in the absence of a deletional rearrangement. Whether this involves a 'transplicing' mechanism or some other mechanism has yet to be determined. Finally, committed IgA B cells emerge from the dual-bearing cell population which express only sIgA. These cells can migrate out of Peyer's patches and respond to various terminal differentiation factors such as IL-5, IL-6 and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955762     DOI: 10.1007/bf02919726

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  4 in total

1.  Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching.

Authors:  D A Lebman; D Y Nomura; R L Coffman; F D Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA.

Authors:  D Y Kunimoto; G R Harriman; W Strober
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

3.  Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures.

Authors:  D A Lebman; F D Lee; R L Coffman
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

4.  Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes.

Authors:  R L Coffman; D A Lebman; B Shrader
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

  4 in total
  4 in total

1.  Effects of Allergina on the treatment of otitis media with effusions.

Authors:  Hyun-Ja Jeong; Seung-Heon Hong; Sung-Chul Kim; Eun-Jeong Park; Chul-Ho Jang; Kyung-Suk Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2002-04       Impact factor: 4.092

2.  Gut Lymphocyte Phenotype Changes After Parenteral Nutrition and Neuropeptide Administration.

Authors:  Mark A Jonker; Aaron F Heneghan; John H Fechner; Joseph F Pierre; Yoshifumi Sano; Jinggang Lan; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

3.  Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: Mutational analysis of putative regulatory binding motifs.

Authors:  Andrew D Snyder; Sharon D Ochs; Brooke E Johnson; Courtney E W Sulentic
Journal:  Mol Immunol       Date:  2020-03-06       Impact factor: 4.407

4.  Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group.

Authors:  T Schneider; R Ullrich; C Bergs; W Schmidt; E O Riecken; M Zeitz
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.